Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för entinostat. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

12 träffar

Bibliografisk träff 2016-05-05

ENGAGE- 501: phase II study of entinostat (SNDX-275) in relapsed and refractory Hodgkin lymphoma.

Batlevi CL, Kasamon Y, Bociek RG, Lee P, Gore L, Copeland A, Sorensen R, Ordentlich P, Cruickshank S, Kunkel L, Buglio D, Hernandez-Ilizaliturri F, Younes A.

Haematologica · clinical trial, phase ii; research support, non-u.s. gov't; research-article; multicenter study; journal article · DOI 10.3324/haematol.2016.142406

Bibliografisk träff 2016-01-01

Discovery of Multi-target Anticancer Agents Based on HDAC Inhibitor MS-275 and 5-FU.

Jiang Y, Li X, Li X, Hou J, Ding Y, Zhang J, Xu W, Zhang Y.

Med Chem · research support, non-u.s. gov't; journal article · DOI 10.2174/1573406411666150714111045

Bibliografisk träff 2015-12-30

The histone deacetylase inhibitor Entinostat enhances polymer-mediated transgene expression in cancer cell lines.

Elmer JJ, Christensen MD, Barua S, Lehrman J, Haynes KA, Rege K.

Biotechnol Bioeng · research support, non-u.s. gov't; research-article; research support, u.s. gov't, non-p.h.s.; journal article; research support, n.i.h., extramural · DOI 10.1002/bit.25898

Bibliografisk träff 2015-08-01

The effect of MS-275 on CYP450 isoforms activity in rats by cocktail method.

Wu Q, Zhang Q, Wen C, Hu L, Wang X, Lin G.

Int J Clin Exp Pathol · research support, non-u.s. gov't; research-article; journal article

Bibliografisk träff 2015-06-22

Entinostat (SNDX-275) for the treatment of non-small cell lung cancer.

Ruiz R, Raez LE, Rolfo C.

Expert Opin Investig Drugs · review; journal article · DOI 10.1517/13543784.2015.1056779

Bibliografisk träff 2014-12-31

The class I histone deacetylase inhibitor MS-275 prevents pancreatic beta cell death induced by palmitate.

Plaisance V, Rolland L, Gmyr V, Annicotte JS, Kerr-Conte J, Pattou F, Abderrahmani A.

J Diabetes Res · research support, non-u.s. gov't; research-article; journal article · DOI 10.1155/2014/195739

Bibliografisk träff 2013-11-06

MS-275, a class I histone deacetylase inhibitor, protects the p53-deficient mouse against ischemic injury.

Murphy SP, Lee RJ, McClean ME, Pemberton HE, Uo T, Morrison RS, Bastian C, Baltan S.

J Neurochem · research-article; journal article; research support, n.i.h., extramural · DOI 10.1111/jnc.12498

Bibliografisk träff 2013-05-01

The histone deacetylase inhibitor, MS-275 (entinostat), downregulates c-FLIP, sensitizes osteosarcoma cells to FasL, and induces the regression of osteosarcoma lung metastases.

Rao-Bindal K, Koshkina NV, Stewart J, Kleinerman ES.

Curr Cancer Drug Targets · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.2174/1568009611313040005

Bibliografisk träff 2012-12-18

HDAC inhibition by SNDX-275 (Entinostat) restores expression of silenced leukemia-associated transcription factors Nur77 and Nor1 and of key pro-apoptotic proteins in AML.

Zhou L, Ruvolo VR, McQueen T, Chen W, Samudio IJ, Conneely O, Konopleva M, Andreeff M.

Leukemia · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1038/leu.2012.366

Bibliografisk träff 2011-07-20

The histone deacetylase inhibitor entinostat (SNDX-275) induces apoptosis in Hodgkin lymphoma cells and synergizes with Bcl-2 family inhibitors.

Jóna A, Khaskhely N, Buglio D, Shafer JA, Derenzini E, Bollard CM, Medeiros LJ, Illés A, Ji Y, Younes A.

Exp Hematol · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1016/j.exphem.2011.07.002

Bibliografisk träff 2002-11-01

MS-27-275, an inhibitor of histone deacetylase, has marked in vitro and in vivo antitumor activity against pediatric solid tumors.

Jaboin J, Wild J, Hamidi H, Khanna C, Kim CJ, Robey R, Bates SE, Thiele CJ.

Cancer Res · journal article

Bibliografisk träff 1999-04-01

A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors.

Saito A, Yamashita T, Mariko Y, Nosaka Y, Tsuchiya K, Ando T, Suzuki T, Tsuruo T, Nakanishi O.

Proc Natl Acad Sci U S A · research-article; journal article · DOI 10.1073/pnas.96.8.4592